Literature DB >> 23053157

Radiation-induced morphological changes in the vagina.

K Kirchheiner1, E Fidarova, R A Nout, M P Schmid, A Sturdza, E Wiebe, A Kranz, S Polterauer, R Pötter, W Dörr.   

Abstract

BACKGROUND AND
PURPOSE: Treatment-induced chronic vaginal changes after definitive radio(chemo)therapy for locally advanced cervical cancer patients are reported as one of the most distressing consequences of treatment, with major impact on quality of life. Although these vaginal changes are regularly documented during gynecological follow-up examinations, the classic radiation morbidity grading scales are not concise in their reporting. The aim of the study was therefore to identify and qualitatively describe, on the basis of vaginoscopies, morphological changes in the vagina after definitive radio(chemo)therapy and to establish a classification system for their detailed and reproducible documentation. PATIENTS AND METHODS: Vaginoscopy with photodocumentation was performed prospectively in 22 patients with locally advanced cervical cancer after definitive radio(chemo)therapy at 3-24 months after end of treatment. All patients were in complete remission and without severe grade 3/4 morbidity outside the vagina.
RESULTS: Five morphological parameters, which occurred consistently after treatment, were identified: mucosal pallor, telangiectasia, fragility of the vaginal wall, ulceration, and adhesions/occlusion. The symptoms in general were observed at different time points in individual patients; their quality was independent of the time of assessment. Based on the morphological findings, a comprehensive descriptive and semiquantitative scoring system was developed, which allows for classification of vaginal changes. A photographic atlas to illustrate the morphology of the alterations is presented.
CONCLUSION: Vaginoscopy is an easily applicable, informative, and well-tolerated procedure for the objective assessment of morphological vaginal changes after radio(chemo)therapy and provides comprehensive and detailed information. This allows for precise classification of the severity of individual changes.

Entities:  

Mesh:

Year:  2012        PMID: 23053157     DOI: 10.1007/s00066-012-0222-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  15 in total

1.  Vaginal changes and sexuality in women with a history of cervical cancer.

Authors:  K Bergmark; E Avall-Lundqvist; P W Dickman; L Henningsohn; G Steineck
Journal:  N Engl J Med       Date:  1999-05-06       Impact factor: 91.245

2.  Post-treatment sexual adjustment following cervical and endometrial cancer: a qualitative insight.

Authors:  I Juraskova; P Butow; R Robertson; L Sharpe; C McLeod; N Hacker
Journal:  Psychooncology       Date:  2003 Apr-May       Impact factor: 3.894

3.  The irradiated vagina.

Authors:  M M Abitbol; J H Davenport
Journal:  Obstet Gynecol       Date:  1974-08       Impact factor: 7.661

4.  Vaginal stenosis following irradiation therapy for carcinoma of the cervix uteri.

Authors:  P Hartman; A W Diddle
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

5.  Congenital vaginal occlusion. Case reports.

Authors:  W T Griffin; J Smith
Journal:  Mo Med       Date:  1968-04

6.  Vaginal fistulae following radiotherapy for carcinoma of the cervix uteri.

Authors:  U Nieminen; L Pöllänen; M Forss
Journal:  Ann Chir Gynaecol Fenn       Date:  1970

7.  A glossary for reporting complications of treatment in gynecological cancers.

Authors:  D Chassagne; P Sismondi; J C Horiot; G Sinistrero; P Bey; P Zola; M Pernot; A Gerbaulet; I Kunkler; G Michel
Journal:  Radiother Oncol       Date:  1993-03       Impact factor: 6.280

8.  MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy.

Authors:  Christine Haie-Meder; Cyrus Chargari; Annie Rey; Isabelle Dumas; Philippe Morice; Nicolas Magné
Journal:  Radiother Oncol       Date:  2010-08       Impact factor: 6.280

9.  Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.

Authors:  Richard Pötter; Johannes Dimopoulos; Petra Georg; Stefan Lang; Claudia Waldhäusl; Natascha Wachter-Gerstner; Hajo Weitmann; Alexander Reinthaller; Tomas Hendrik Knocke; Stefan Wachter; Christian Kirisits
Journal:  Radiother Oncol       Date:  2007-05       Impact factor: 6.280

10.  Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.

Authors:  D W Bruner; R Lanciano; M Keegan; B Corn; E Martin; G E Hanks
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-11-15       Impact factor: 7.038

View more
  8 in total

1.  Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancer.

Authors:  P Georg; A Boni; A Ghabuous; G Goldner; M P Schmid; D Georg; R Pötter; W Dörr
Journal:  Strahlenther Onkol       Date:  2013-05-25       Impact factor: 3.621

2.  Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers.

Authors:  Marisa R Moroney; Dina Flink; Jeanelle Sheeder; Erin A Blake; Aakriti R Carrubba; Christine M Fisher; Saketh R Guntupalli
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-13

3.  Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors.

Authors:  Allison M Quick; Travis Dockter; Jennifer Le-Rademacher; Ritu Salani; Catherine Hudson; Andrew Hundley; Shelby Terstriep; Lauren Streicher; Stephanie Faubion; Charles L Loprinzi; Jenell S Coleman; Karen C Wang; Maryam Lustberg
Journal:  Maturitas       Date:  2020-12-02       Impact factor: 4.342

Review 4.  Radiation-induced vaginal stenosis: current perspectives.

Authors:  Lucinda Morris; Viet Do; Jennifer Chard; Alison H Brand
Journal:  Int J Womens Health       Date:  2017-05-02

5.  High-dose-rate brachytherapy for high-grade vaginal intraepithelial neoplasia: a dosimetric analysis.

Authors:  Amelia Barcellini; Mara Lecchi; Chiara Tenconi; Alessandra Macciotta; Emanuele Pignoli; Brigida Pappalardi; Ester Mazzarella; Mauro Carrara; Tommaso Giandini; Carlo Fallai; Paolo Verderio; Annamaria Cerrotta
Journal:  J Contemp Brachytherapy       Date:  2019-04-29

6.  Vaginal dose of radical radiotherapy for cervical cancer in China: a multicenter study.

Authors:  Juan Wang; Kai-Shuo Zhang; Tao Wang; Zi Liu; Rui-Hua Wang; Fu-Quan Zhang; Lang Yu; Li Ran; Jian-Li He; Ya-Li Wang; Li-Chun Wei; Mei Shi; Guo-Qing Wang; Chao-Qun Wu; Qi-Jun Kang; Jie Yang; Sha Li; Fei-Yue Yang; Bao-Gang Liu; Juan-Yue Liu; Fan Shi; Jin Su; Wei Yuan; Emmanuel Kwateng Drokow
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

Review 7.  Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training.

Authors:  Amelia Barcellini; Mattia Dominoni; Francesca Dal Mas; Helena Biancuzzi; Sara Carla Venturini; Barbara Gardella; Ester Orlandi; Kari Bø
Journal:  Front Med (Lausanne)       Date:  2022-02-03

8.  Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Authors:  Toru Sugiyama; Noriyuki Katsumata; Takafumi Toita; Masako Ura; Ayaka Shimizu; Shuichi Kamijima; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2022-06-27       Impact factor: 3.850

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.